CompletedNot Applicable

The Effect of Tranexamic Acid in Endoscopic and Microscopic Ear Surgery Cases on Surgeon Satisfaction

Turkey (Türkiye)100 participantsStarted 2024-12-01

Plain-language summary

By using tranexamic acid, an antifibrinolytic drug, the aim is to prevent the restriction of the field of view of the surgical field due to bleeding in middle ear microscopic and endoscopic surgery operations in which controlled hypotension is applied, and therefore the prolongation of the surgical time, and to increase surgeon satisfaction.

Who can participate

Age range18 Years – 65 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Individuals between the ages of 18-65 * Individuals with ASA I (no additional disease) or ASA II (mild systemic disease) * Those who do not have a disease such as thrombophilia or bleeding diathesis will be included in the study Exclusion Criteria: * Patients with ASA III (those with uncontrolled chronic disease) or above * Patients with cardiovascular disease, congestive heart failure, coronary artery disease, cerebrovascular insufficiency, renal or hepatic failure * Patients with thrombophilia, bleeding diathesis, coagulation defects * Pregnant patients * Those with a history of any allergic reaction to tranexamic acid and its derivatives will be excluded from the study

What they're measuring

Boezaart et al grading scale

Timeframe: 2-3 hours

Surgeon Satisfaction Score

Timeframe: 2-3 hours

Trial details

NCT IDNCT06434636

SponsorTC Erciyes University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-05-05

View on ClinicalTrials.gov More Middle Ear Disease trials